E-Prescribing Market Report 2026

The e-prescribing market size has grown exponentially in recent years. It will grow from $3.31 billion in 2025 to $4.15 billion in 2026 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to healthcare digitalization initiatives, medication error reduction needs, hospital it adoption, regulatory support for e-health, pharmacy system integration.

The e-prescribing market size is expected to see exponential growth in the next few years. It will grow to $10.14 billion in 2030 at a compound annual growth rate (CAGR) of 25%. The growth in the forecast period can be attributed to ai-driven clinical decision support, telehealth expansion, cybersecurity investments, nationwide digital health programs, interoperability standards. Major trends in the forecast period include increasing adoption of digital prescription platforms, growth in cloud-based healthcare solutions, integration with electronic health records, expansion of telemedicine and remote care, emphasis on reducing medication errors.

The increasing emphasis on reducing medical errors is expected to drive the growth of the e-prescribing market in the coming years. Medical errors refer to preventable adverse effects of medical care on patients. E-prescribing has played a significant role in minimizing errors caused by illegible physician handwriting. For instance, in May 2023, the National Library of Medicine, a US-based medical library, reported that medical errors in hospitals and clinics result in approximately 100,000 deaths annually. Therefore, the growing focus on reducing medical errors is fueling the expansion of the e-prescribing market.

Major companies in the e-prescribing market are focusing on technological advancements such as automated prior authorization systems to improve prescription efficiency, reduce clinician workload, and accelerate therapy initiation. An automated prior authorization system gathers the necessary clinical data from a patient’s electronic health record (EHR) and submits it to the payer (PBM) without manual intervention, allowing for faster approvals, fewer denials, and reduced administrative work compared to traditional manual processes. For instance, in February 2025, Surescripts, a US-based health information network, launched Touchless Prior Authorization, an innovative e-prescribing solution. The system automatically collects clinical data, sends authorization requests to payers, provides real-time status updates, and reduces approval times from days to seconds, streamlining workflow for prescribers and improving patient care by eliminating manual steps from the prior authorization process.

In March 2023, PRN Software, LLC, a US-based healthcare software company, acquired Bravado Health for an undisclosed amount. Through this acquisition, PRN Software aims to expand its e-prescribing solutions, enhance patient safety and compliance, drive innovation and growth, and provide improved support for healthcare providers. Bravado Health is a US-based digital health technology company that enhances patient care by integrating e-prescribing into its digital health platform.

Major companies operating in the e-prescribing market are Epic Systems Corporation, Allscripts Healthcare Solutions Inc., NextGen Healthcare Inc., Athenahealth, Henry Schein Inc., Computer Programs and Systems Inc., DrFirst.com Inc., Surescripts, Medical Information Technology, Change Healthcare, Health Fusion Inc., eMDs Inc., Cerner Corporation, Practice Fusion Inc., eClinicalWorks LLC, Greenway Health LLC, AdvancedMD Inc., Kareo Inc., PracticeSuite Inc., Advanced Data Systems Corporation, Aprima Medical Software Inc., Compulink Healthcare Solutions, CureMD Healthcare, MacPractice Inc., Medsphere Systems Corporation, Modernizing Medicine Inc., NueMD LLC, Office Ally Inc., Optum Inc., PatientNOW Inc., Sevocity Inc.

North America was the largest region in the e-prescribing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the e-prescribing market during the forecast period. The regions covered in the e-prescribing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the e-prescribing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the e-prescribing market by increasing costs of imported healthcare software infrastructure, cloud hardware, and IT services. Hospitals and office-based physicians in developed regions are most affected due to reliance on imported digital systems. These tariffs raise implementation costs by increasing expenses related to system deployment, cybersecurity, and maintenance, slowing adoption of digital prescribing platforms. However, they encourage local health IT development, fostering regionally built e-prescribing solutions tailored to domestic regulatory environments.

The e-prescribing market research report is one of a series of new reports that provides e-prescribing market statistics, including e-prescribing industry global market size, regional shares, competitors with a e-prescribing market share, detailed e-prescribing market segments, market trends and opportunities, and any further data you may need to thrive in the e-prescribing industry. This e-prescribing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

E-prescribing is a technological system that enables physicians and other healthcare providers to create and transmit prescriptions electronically to participating pharmacies, replacing handwritten notes, faxes, or phone-in prescriptions.

The primary components of e-prescribing include solutions and services. Services refer to the intangible, non-physical aspects of the system, as opposed to tangible goods. E-prescribing can be deployed through web-based, cloud-based, or on-premise platforms. The main end users include hospitals, office-based physicians, and pharmaceutical companies.

The e-prescribing market consists of sales of software and services related to software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.